Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,110.00    -20.00 (-0.28%)
Bid:
7,105.00
Ask:
7,115.00
Spread: 10.00 (0.141%)
Market Cap: £9.53b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Trading Statement

25 Mar 2013 07:00

RNS Number : 6946A
Diploma PLC
25 March 2013
 



 

DIPLOMA PLC

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX

TELEPHONE: +44 (0)20 7549 5700

FACSIMILE: +44 (0)20 7549 5715

 

FOR IMMEDIATE RELEASE

 

25 March 2013

 

 

DIPLOMA PLC

 

TRADING UPDATE

 

 

Diploma PLC, the international group of businesses supplying specialised technical products and services, is today issuing a trading update for the six months ending 31 March 2013, ahead of going into close period.

 

Trading Summary

Overall trading continues to be consistent with the Board's expectations at the time of the Interim Management Statement in January, against the macroeconomic backdrop which remains challenging, particularly in Europe. Group revenues are expected to be ca. 10% ahead of the comparable period last year, helped by a good contribution from businesses acquired during the past year. On an underlying basis, after adjusting for currency effects and acquisitions, revenues are expected to increase by ca. 3% against strong prior year comparatives.

 

The main contribution to revenue growth has been from Life Sciences where revenues have benefited from both the acquisition of DSL in June last year and from strong growth in consumable and service revenues across the businesses, which reflects the resilience of the Healthcare markets. In Seals, revenues have benefited from the acquisition of J Royal in December 2011, but underlying revenue growth is likely to be limited, given the very strong prior year comparatives, particularly in the Aftermarket businesses. In Controls, revenues have benefited from the small acquisitions completed during the past year, but the continuing weak trading conditions in Europe are likely to lead to a small decline in underlying revenue in the first half of the year.

 

Operating margins have reduced in line with expectations from record levels last year, reflecting the impact of implementing the Board's programme of planned investments to support the future growth of the business. This programme has included additional management resource to accelerate and broaden the acquisition programme. Acquisitions are an integral part of the Group's growth strategy and the pipeline of opportunities remains promising, although the current uncertain economic background has lengthened the transaction processes.

 

With a resilient business model, a good geographic spread of activities and contributions from acquisitions, the Board remains confident that further progress will be made in the second half of the year.

 

Financial Position

The Group has a robust balance sheet and has a proven track record of strong cash generation. At 31 March 2013 the Group will be in a strong net cash position, after payments of ca. £1.5m on acquisitions during the half year, seasonal working capital outflows and capital investment in the businesses.

 

The Group's results for the six months ending 31 March 2013 will be announced on Monday, 13 May 2013.

 

 

Conference Call:

 

A conference call for analysts and investors will take place at 8.00am (GMT) this morning; please contact Tulchan Communications for details.

 

 

Note: A copy of this Statement, together with further information about Diploma PLC, may be viewed on its website at www.diplomaplc.com

 

Diploma PLC -

+44 (0)20 7549 5700

Bruce Thompson, Chief Executive Officer

Nigel Lingwood, Group Finance Director

Tulchan Communications -

+44 (0)20 7353 4200

David Allchurch

Martin Robinson

 

 

NOTE TO EDITORS:

 

Diploma PLC is an international group of businesses supplying specialised technical products and services to the Life Sciences, Seals and Controls industries.

 

Diploma's businesses are focussed on supplying essential products and services which are funded by the customers' operating rather than their capital budgets, providing recurring income and stable revenue growth.

 

Our businesses then design their individual business models to closely meet the requirements of their customers, offering a blend of high quality customer service, deep technical support and value adding activities. By supplying essential solutions, not just products, we build strong long term relationships with our customers and suppliers, which support attractive and sustainable margins.

 

Finally we encourage an entrepreneurial culture in our businesses through our decentralised management structure. We want our managers to feel that they have the freedom to run their own businesses, while being able to draw on the support and resources of a larger group. These essential values ensure that decisions are made close to the customer and that the businesses are agile and responsive to changes in the market and the competitive environment.

 

The Group employs ca. 1,200 employees and its principal operating businesses are located in the UK, Germany, US, Canada and Australia.

 

Over the last five years, the Group has grown adjusted earnings per share at an average of ca. 20% pa through a combination of organic growth and acquisitions. Diploma is a member of the FTSE 250 with a market capitalisation of ca. £680m.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPGUGAWUPWGCP
Date   Source Headline
14th Feb 202510:34 amRNSHolding(s) in Company
17th Jan 20259:34 amRNSDirector/PDMR Shareholding
15th Jan 20252:56 pmRNSResult of AGM
15th Jan 202510:19 amRNSAppointment of Non-Executive Director
15th Jan 20257:00 amRNS1st Quarter Results
10th Jan 20258:56 amRNSDirector/PDMR Shareholding
23rd Dec 20247:00 amRNSDirector/PDMR Shareholding
9th Dec 20247:00 amRNSAnnual Financial Report & Notice of AGM
5th Dec 20244:25 pmRNSHolding(s) in Company
3rd Dec 20244:39 pmRNSHolding(s) in Company
2nd Dec 20247:00 amRNSTotal Voting Rights
27th Nov 20247:00 amRNSBoard Committee Changes
27th Nov 20247:00 amRNSDirector/PDMR Grant of LTIP Awards
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSPreliminary Results
15th Nov 20247:00 amRNSIssue of Shares & Total Voting Rights
8th Oct 20247:00 amRNSAppointment of Non-Executive Director
13th Sep 20247:00 amRNSAppointment of Senior Independent Director
29th Jul 20242:25 pmRNSDirector Declaration
18th Jul 20247:00 amRNSQ3 Trading Statement
16th Jul 20247:00 amRNSBoard Changes
4th Jun 202411:18 amRNSHolding(s) in Company
13th May 20247:00 amRNSHalf Year Results
2nd May 20247:00 amRNSAcquisition
25th Apr 20243:54 pmRNSHolding(s) in Company
3rd Apr 20247:00 amRNSHolding(s) in Company
27th Mar 20247:00 amRNSAcquisition
5th Mar 20242:07 pmRNSHolding(s) in Company
17th Jan 20243:21 pmRNSResult of AGM
17th Jan 20247:00 amRNSQ1 trading update
20th Dec 20237:00 amRNSAppointment of Non-Executive Director
18th Dec 20237:00 amRNSDirector/PDMR Shareholding
14th Dec 202311:31 amRNSHolding(s) in Company
11th Dec 20237:00 amRNSAnnual Financial Report & Notice of AGM
5th Dec 20233:00 pmRNSDirector/PDMR Shareholding
1st Dec 20237:00 amRNSTotal Voting Rights
28th Nov 20237:00 amRNSDirector/PDMR Grant of LTIP Awards
21st Nov 20237:00 amRNSDirector/PDMR Shareholding
20th Nov 20237:00 amRNSFull Year Results
16th Nov 20237:00 amRNSIssue of Shares & Total Voting Rights
10th Oct 202312:29 pmRNSHolding(s) in Company
21st Aug 202310:10 amRNSHolding(s) in Company
15th Aug 20233:54 pmRNSHolding(s) in Company
18th Jul 20237:00 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSStrategic acquisition in European Fluid Power
13th Jul 20237:00 amRNSQ3 Trading Update
27th Jun 20237:00 amRNSCapital Markets Seminar
13th Jun 20235:09 pmRNSHolding(s) in Company
7th Jun 20233:49 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.